Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA GSK PHARMA NATCO PHARMA/
GSK PHARMA
 
P/E (TTM) x 13.3 62.2 21.4% View Chart
P/BV x 3.5 18.9 18.5% View Chart
Dividend Yield % 0.6 1.6 35.1%  

Financials

 NATCO PHARMA   GSK PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
GSK PHARMA
Mar-23
NATCO PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs8471,684 50.3%   
Low Rs5021,231 40.8%   
Sales per share (Unadj.) Rs148.4191.9 77.3%  
Earnings per share (Unadj.) Rs39.235.9 109.3%  
Cash flow per share (Unadj.) Rs48.239.8 121.2%  
Dividends per share (Unadj.) Rs5.5032.00 17.2%  
Avg Dividend yield %0.82.2 37.1%  
Book value per share (Unadj.) Rs267.1102.9 259.6%  
Shares outstanding (eoy) m182.47169.41 107.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.57.6 59.9%   
Avg P/E ratio x17.240.6 42.3%  
P/CF ratio (eoy) x14.036.7 38.2%  
Price / Book Value ratio x2.514.2 17.8%  
Dividend payout %14.089.2 15.7%   
Avg Mkt Cap Rs m123,049246,858 49.8%   
No. of employees `000NANA-   
Total wages/salary Rs m4,8675,950 81.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,07132,517 83.3%  
Other income Rs m1,2851,007 127.7%   
Total revenues Rs m28,35633,524 84.6%   
Gross profit Rs m9,1178,033 113.5%  
Depreciation Rs m1,638658 249.1%   
Interest Rs m14518 800.2%   
Profit before tax Rs m8,6198,364 103.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4662,288 64.1%   
Profit after tax Rs m7,1536,076 117.7%  
Gross profit margin %33.724.7 136.3%  
Effective tax rate %17.027.4 62.2%   
Net profit margin %26.418.7 141.4%  
BALANCE SHEET DATA
Current assets Rs m30,00324,943 120.3%   
Current liabilities Rs m6,83113,264 51.5%   
Net working cap to sales %85.635.9 238.3%  
Current ratio x4.41.9 233.6%  
Inventory Days Days6397 65.3%  
Debtors Days Days115216 53.5%  
Net fixed assets Rs m26,5716,988 380.3%   
Share capital Rs m3651,694 21.5%   
"Free" reserves Rs m48,37315,735 307.4%   
Net worth Rs m48,73817,430 279.6%   
Long term debt Rs m00-   
Total assets Rs m56,57431,930 177.2%  
Interest coverage x60.4462.6 13.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.51.0 47.0%   
Return on assets %12.919.1 67.6%  
Return on equity %14.734.9 42.1%  
Return on capital %18.048.1 37.4%  
Exports to sales %00-   
Imports to sales %10.248.1 21.3%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2,77215,630 17.7%   
Fx inflow Rs m17,2561,622 1,064.1%   
Fx outflow Rs m2,77215,630 17.7%   
Net fx Rs m14,484-14,008 -103.4%   
CASH FLOW
From Operations Rs m8,4914,842 175.4%  
From Investments Rs m-4,7718,079 -59.1%  
From Financial Activity Rs m-3,630-15,433 23.5%  
Net Cashflow Rs m208-2,512 -8.3%  

Share Holding

Indian Promoters % 49.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 25.0 11.6 215.6%  
FIIs % 13.7 2.9 468.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 25.0 201.2%  
Shareholders   207,571 114,663 181.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs GSK Pharma Share Price Performance

Period Natco Pharma GSK Pharma S&P BSE HEALTHCARE
1-Day -2.11% 3.26% 1.18%
1-Month -3.19% -9.77% -0.75%
1-Year 72.80% 52.63% 61.82%
3-Year CAGR 4.96% 10.89% 18.16%
5-Year CAGR 10.96% 8.44% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.